Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin, David H. Miller, Mark S. Freedman, Bruce A. C. Cree, Jerry S. Wolinsky, Howard Weiner, Catherine Lubetzki, Hans-Peter Hartung, Xavier Montalban, Bernard M. J. Uitdehaag, Martin Merschhemke, Bingbing Li, Norman Putzki, Fonda C. Liu, Dieter A. Haering, Ludwig Kappos
- Icahn School of Medicine at Mount Sinai (ISMMS)
- Queen Mary University of London (QMU)
- University of Ottawa
- Univ Calif San Diego, University of California System, University of California San Diego
- UNIV TEXAS, University of Texas System, UTMD Anderson Cancer Center
- Harvard University
- Assistance publique - Hôpitaux de Paris
- Heinrich Heine University Düsseldorf (HHU)
- Vrije Universiteit Amsterdam (VU)
- Novartis Pharma AG
- University of Basel
Producción científica: Contribución a una revista › Artículo › Investigación › revisión exhaustiva
390
El enlace se abre en una pestaña nueva
Citas
(Scopus)